Press release
Dry Age Related Macular Degeneration (AMD) Market Poised for 8.8 % Growth, Set to Hit $6.86 Billion by 2029
Which drivers are expected to have the greatest impact on the over the dry age related macular degeneration (amd) market's growth?The growing geriatric population is expected to drive the growth of the dry age-related macular degeneration (AMD) market. As medical advancements and improved chronic disease management have increased life expectancy, the number of older adults is steadily rising. Dry AMD, a leading cause of vision impairment among the elderly, provides targeted treatments aimed at slowing disease progression and preserving vision. With 57.8 million adults aged 65 and older in the U.S. in 2022, representing 17.3% of the total population, the growing geriatric demographic presents a growing market for AMD treatments.
Get Your Dry Age Related Macular Degeneration (AMD) Market Report Here:
https://www.thebusinessresearchcompany.com/report/dry-age-related-macular-degeneration-amd-global-market-report
What is the future CAGR of the dry age related macular degeneration (amd) market, and how will it impact industry expansion?
The dry age-related macular degeneration (AMD) market is experiencing steady growth, increasing from $4.49 billion in 2024 to $4.90 billion in 2025 at a CAGR of 9.1%. The historical growth factors include a rising aging population, an increased prevalence of chronic diseases, growing awareness of eye health, a rising number of clinical trials focused on dry AMD, and a growing demand for minimally invasive treatments.
The dry age-related macular degeneration (AMD) market is projected to experience significant growth, reaching $6.86 billion by 2029 at a CAGR of 8.8%. This expansion will be driven by the emergence of novel therapies, increased healthcare spending, rising use of laser photocoagulation therapy, progress in genetic research, and a heightened focus on personalized medicine. Key trends include advancements in diagnostic technologies, the growing adoption of teleophthalmology, cutting-edge treatment options, regulatory approvals, and the launch of new products.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21176&type=smp
What are the most significant trends transforming the dry age related macular degeneration (amd) market today?
In the dry age-related macular degeneration (AMD) market, companies are innovating with light delivery systems to activate retinal cells and slow disease progression. For example, in January 2024, LumiThera Inc., a US-based medical device company, launched the Valeda Light Delivery System for treating dry AMD. This FDA-authorized photobiomodulation (PBM) therapy uses multi-wavelength light (590 nm, 660 nm, and 850 nm) to target retinal cells, offering a non-invasive treatment option. LumiThera also initiated the EUROLIGHT registry study to gather long-term data on the system's effectiveness in improving vision in dry AMD patients.
Which key market segments comprise the dry age related macular degeneration (amd) market and drive its revenue growth?
The dry age related macular degeneration (AMD) market covered in this report is segmented -
1) By Stages: Early Age-Related Macular Degeneration, Intermediate Age-Related Macular Degeneration, Late Age-Related Macular Degeneration
2) By Age Group: Above 75 Years, Above 60 Years, Above 40 Years
3) By Route Of Administration: Oral, Injectables
4) By End Users: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes
Subsegments:
1) By Early Age-Related Macular Degeneration: Drusen Accumulation, Retinal Pigment Epithelium Changes
2) By Intermediate Age-Related Macular Degeneration: Larger Drusen Deposits, Increased Pigmentary Abnormalities
3) By Late Age-Related Macular Degeneration: Geographic Atrophy, Central Vision Loss
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21176
What regions are at the forefront of dry age related macular degeneration (amd) market expansion?
North America was the largest region in the dry age-related macular degeneration (AMD) market in 2024. The regions covered in the dry age related macular degeneration (AMD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the leading players fueling growth in the dry age related macular degeneration (amd) market?
Major companies operating in the dry age related macular degeneration (AMD) market are F Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Amgen Inc., Biogen Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Lupin Ltd., Santen Pharmaceuticals Inc., Biocon Ltd., Alimera Sciences Inc., Apellis Pharmaceuticals Inc., Belite Bio Inc., Axol Bioscience Ltd., Alkeus Pharmaceuticals Inc., Kubota Holdings Co., Ribomic Inc., Eyestem Research Pvt. Ltd., LumiThera Inc., Adverum Biotechnologies Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21176&type=smp
What Is Covered In The Dry Age Related Macular Degeneration (AMD) Global Market Report?
•Market Size Forecast: Examine the dry age related macular degeneration (amd) market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the dry age related macular degeneration (amd) market for a structured understanding.
•Key Players Overview: Analyze major players in the dry age related macular degeneration (amd) market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the dry age related macular degeneration (amd) market.
•Segment Contributions: Evaluate how different segments drive overall growth in the dry age related macular degeneration (amd) market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the dry age related macular degeneration (amd) market.
•Industry Challenges: Identify potential risks and obstacles affecting the dry age related macular degeneration (amd) market.
•Competitive Landscape: Review strategic developments in the dry age related macular degeneration (amd) market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dry Age Related Macular Degeneration (AMD) Market Poised for 8.8 % Growth, Set to Hit $6.86 Billion by 2029 here
News-ID: 3934463 • Views: …
More Releases from The Business Research Company

Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…

Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…

Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…

Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for AMD
Onlive Server Brings AI-Powered AMD Dedicated Servers
We are all aware of how useful, and sometimes even crucial, proper hosting services can be for a business. That is why Onlive Server is providing this new option with the newly recommended AI-powered AMD Dedicated Server Hosting[https://onliveserver.com/amd-dedicated-server-hosting/]. Furthermore, these servers are powered by AMD technology and do superbly in servicing the tremendous demand of agile business workloads with modern AI computations, big data, and other emerging technologies.
AI-powered solutions are…
Age-Related Macular Degeneration Market To Expand, Fuelled By Innovations In Dry …
The Age-related Macular Degeneration Market (AMD) is poised for significant growth over the coming years, with projections indicating a compound annual growth rate (CAGR) of 6.2%, leading to an estimated market value of $20 billion by the end of the forecast period. This robust expansion is driven by several critical factors, including the rising prevalence of eye diseases, advancements in medical technology, and an aging population that is increasingly susceptible…
AMD Workstations Market | BIZON, BOXX Technologies, Broadberry, Dell
The global amd workstations market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the amd workstations market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth of the…
Airway Management Products (AMD) Market 2021 | Detailed Report
Airway Management Products (AMD) Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5262437
The report provides a comprehensive analysis of company profiles listed below:
- Medtronic
- Teleflex
- Ambu
- Smiths Medical
- Intersurgical
- Becton Dickinson
- Armstrong Medical
- Medline Industries
Airway Management Products…
Age-Related Macular Degeneration (AMD) Market Report 2018: Segmentation by Type …
Global Age-Related Macular Degeneration (AMD) market research report provides company profile for F. Hoffmann-La Roche AG, Regeneron Pharmaceutical Inc., Novartis AG, Bayer AG, Santen Pharmaceuticals and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc.…
Global Microprocessor Market 2018 - Intel, Qualcomm, Apple, AMD
Apex Market Reports, recently published a detailed market research study focused on the “Microprocessor Market” across the global, regional and country level. The report provides 360° analysis of “Microprocessor Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Microprocessor on the basis of…